Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy

NCT03633266 is registered in ClinicalTrials.gov with Wenzhou Medical University as lead sponsor.

NCT NCT03633266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03633266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy
Lead sponsor
Wenzhou Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2018
Completion date
December 1, 2022
Enrollment
220 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anti-vegf, proliferative diabetic retinopathy, prp, vitrectomy